.
MergerLinks Header Logo

New Deal


Announced

Completed

Taikang Asset Management led a $113m series B round in Sanbo Brain Hospital.

Financials

Edit Data
Transaction Value£91m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Private Equity

Health Care Facilities

Friendly

Private

China

healthcare facility

Completed

hospital and clinics

Acquisition

Single Bidder

Minority

neurology

Synopsis

Edit

Private equity firm Taikang Asset Management led a $113m series B round in Sanbo Brain Hospital, a neurology specialist. Chinese investment bank CEC Capital, healthcare fund Park Road Medical Investment, Beijing-based equity investment firm Broadhi Capital, and Beijing Puhong Investment Fund Management participated in the financing. “The neurology field has a market of massive demand as well as a high technical barrier. Taikang will actively explore cooperation opportunities with Sanbo in the fields of health insurance and healthcare management to bring better service experience to insurance customers," Xu Jun, Taikang Partner.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US